1. Pathologic TDP-43 downregulates myelin gene expression in the monkey brain.
- Author
-
Zhu L, Bai D, Wang X, Ou K, Li B, Jia Q, Tan Z, Liang J, He D, Yan S, Wang L, Li S, Li XJ, and Yin P
- Subjects
- Animals, Male, Corpus Callosum metabolism, Corpus Callosum pathology, Demyelinating Diseases pathology, Demyelinating Diseases metabolism, Demyelinating Diseases genetics, Down-Regulation, Myelin Sheath metabolism, Myelin Sheath pathology, Myelin Sheath genetics, Oligodendroglia metabolism, Oligodendroglia pathology, Macaca fascicularis, Brain metabolism, Brain pathology, DNA-Binding Proteins metabolism, DNA-Binding Proteins genetics
- Abstract
Growing evidence indicates that non-neuronal oligodendrocyte plays an important role in Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. In patient's brain, the impaired myelin structure is a pathological feature with the observation of TDP-43 in cytoplasm of oligodendrocyte. However, the mechanism underlying the gain of function by TDP-43 in oligodendrocytes, which are vital for the axonal integrity, remains unclear. Recently, we found that the primate-specific cleavage of truncated TDP-43 fragments occurred in cytoplasm of monkey neural cells. This finding opened up the avenue to investigate the myelin integrity affected by pathogenic TDP-43 in oligodendrocytes. In current study, we demonstrated that the truncated TDP-35 in oligodendrocytes specifically, could lead to the dysfunctional demyelination in corpus callosum of monkey. As a consequence of the interaction of myelin regulatory factor with the accumulated TDP-35 in cytoplasm, the downstream myelin-associated genes expression was downregulated at the transcriptional level. Our study aims to investigate the potential effect on myelin structure injury, affected by the truncated TDP-43 in oligodendrocyte, which provided the additional clues on the gain of function during the progressive pathogenesis and symptoms in TDP-43 related diseases., (© 2024 The Author(s). Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.)
- Published
- 2024
- Full Text
- View/download PDF